(Q34743328)

4 August 2017

1 reference

title

New therapeutics that modulate chemokine networks (English)

1 reference

4 August 2017

Matthias K Schwarz

1

1 reference

4 August 2017

Timothy N C Wells

series ordinal

2

1 reference

4 August 2017

publication date

1 May 2002

1 reference

Nature Reviews Drug Discovery

4 August 2017

published in

1 reference

4 August 2017

volume

1

1 reference

4 August 2017

issue

5

1 reference

4 August 2017

page(s)

347-358

1 reference

Structure and Functional Expression of a Human Interleukin-8 Receptor

4 August 2017

cites work

1 reference

Cloning of complementary DNA encoding a functional human interleukin-8 receptor

21 January 2018

1 reference

Is there a 'lock' for all agonist 'keys' in 7TM receptors?

21 January 2018

1 reference

The strategy of blocking the chemokine system to combat disease

21 January 2018

1 reference

21 January 2018

Chemokines and disease

1 reference

Chemokines: a new classification system and their role in immunity

21 January 2018

1 reference

High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR

21 January 2018

1 reference

Analysis of hydrophobicity in the alpha and beta chemokine families and its relevance to dimerization

21 January 2018

1 reference

A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus.

21 January 2018

1 reference

Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors

21 January 2018

1 reference

The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3

21 January 2018

1 reference

Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration

21 January 2018

1 reference

Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1

21 January 2018

1 reference

Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor

21 January 2018

1 reference

Discovery of novel non-peptide CCR1 receptor antagonists

21 January 2018

1 reference

CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis.

21 January 2018

1 reference

CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model

21 January 2018

1 reference

A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection

21 January 2018

1 reference

Interfering with chemokine networks--the hope for new therapeutics

21 January 2018

1 reference

Recent developments in modulating chemokine networks

21 January 2018

1 reference

A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation

21 January 2018

1 reference

Species selectivity of a small molecule antagonist for the CCR1 chemokine receptor

21 January 2018

1 reference

Design, synthesis, and discovery of a novel CCR1 antagonist

21 January 2018

1 reference

A small-molecule antagonist of human and murine CCR1 receptors

21 January 2018

1 reference

Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: lessons from knockout mice

21 January 2018

1 reference

Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle

21 January 2018

1 reference

CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compound

21 January 2018

1 reference

Conformationally restricted indolopiperidine derivatives as potent CCR2B receptor antagonists

21 January 2018

1 reference

A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry.

21 January 2018

1 reference

Discovery of a novel CCR3 selective antagonist

21 January 2018

1 reference

Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration

21 January 2018

1 reference

Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1.

21 January 2018

1 reference

Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2.

21 January 2018

1 reference

A report from the International Eosinophil Society: eosinophils in a tug of war.

21 January 2018

1 reference

Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis.

21 January 2018

1 reference

HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use

21 January 2018

1 reference

Discovery of 4-[(Z)-(4-bromophenyl)- (ethoxyimino)methyl]-1'-[(2,4-dimethyl-3- pyridinyl)carbonyl]-4'-methyl-1,4'- bipiperidine N-oxide (SCH 351125): an orally bioavailable human CCR5 antagonist for the treatment of HIV infection

21 January 2018

1 reference

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo

21 January 2018

1 reference

Piperazine-based CCR5 antagonists as HIV-1 inhibitors. I: 2(S)-methyl piperazine as a key pharmacophore element

21 January 2018

1 reference

Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoromethyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-oxide (Sch-350634), an orally bioavailabl

21 January 2018

1 reference

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. part 1: discovery and initial structure-activity relationships for 1 -amino-2-phenyl-4-(piperidin-1-yl)butanes

21 January 2018

1 reference

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: structure-activity relationships for substituted 2-Aryl-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-(piperidin-1-yl)butanes

21 January 2018

1 reference

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 3: a proposed pharmacophore model for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-[4-(substituted)piperidin-1-yl]butanes

21 January 2018

1 reference

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 4: synthesis and structure-activity relationships for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N-(benzyloxycarbonyl)amino)piperidin-1-yl)butanes

21 January 2018

1 reference

Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infection

21 January 2018

1 reference

Discovery of human CCR5 antagonists containing hydantoins for the treatment of HIV-1 infection

21 January 2018

1 reference

1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 1: discovery of the pyrrolidine scaffold and determination of its stereochemical requirements

21 January 2018

1 reference

1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: lead optimization affording selective, orally bioavailable compounds with potent anti-HIV activity

21 January 2018

1 reference

Combinatorial synthesis of CCR5 antagonists

21 January 2018

1 reference

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

21 January 2018

1 reference

Discovery of novel, potent, and selective small-molecule CCR5 antagonists as anti-HIV-1 agents: synthesis and biological evaluation of anilide derivatives with a quaternary ammonium moiety

21 January 2018

1 reference

Inhibitory effects of small-molecule CCR5 antagonists on human immunodeficiency virus type 1 envelope-mediated membrane fusion and viral replication

21 January 2018

1 reference

Novel low molecular weight spirodiketopiperazine derivatives potently inhibit R5 HIV-1 infection through their antagonistic effects on CCR5.

21 January 2018

1 reference

Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4

21 January 2018

1 reference

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

21 January 2018

1 reference

Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-azamacrocycles that inhibit HIV-1 and HIV-2 replication by antagonism of the chemokine receptor CXCR4

21 January 2018

1 reference

Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers

21 January 2018

1 reference

AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice.

21 January 2018

1 reference

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

An interleukin 5 mutant distinguishes between two functional responses in human eosinophils.

21 January 2018

1 reference

Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues

21 January 2018

1 reference

RANTES and MCP-3 antagonists bind multiple chemokine receptors

21 January 2018

1 reference

An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model

21 January 2018

1 reference

Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist.

21 January 2018

1 reference

Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.

21 January 2018

1 reference

CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: role of signal transduction

21 January 2018

1 reference

Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity

21 January 2018

1 reference

Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses

21 January 2018

1 reference

Nicotinamide N-oxides as CXCR2 antagonists

31 March 2020

1 reference

Selective lymphocyte chemokine receptor expression in the rheumatoid joint

31 March 2020

1 reference

Identification of a potent and nonpeptidyl ccr3 antagonist

31 March 2020

1 reference

HIV-1 entry inhibitors: evading the issue

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRD795

1 reference

release_ob2qqaed2ndfrlba6bw2ylc3ry

4 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ob2qqaed2ndfrlba6bw2ylc3ry

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference